Babesiosis due to Babesia duncani
ICD-10 B60.02 is a billable code used to indicate a diagnosis of babesiosis due to babesia duncani.
Babesiosis is a protozoal infection caused by the Babesia species, with Babesia duncani being one of the notable strains affecting humans. This disease is primarily transmitted through the bite of infected Ixodes ticks, commonly known as deer ticks. The clinical presentation of babesiosis can range from asymptomatic to severe illness, particularly in individuals with compromised immune systems or those who are splenectomized. Symptoms typically include fever, chills, sweats, headache, myalgia, and fatigue. Laboratory findings may reveal hemolytic anemia, thrombocytopenia, and elevated liver enzymes. Diagnosis is confirmed through serological tests or microscopic examination of blood smears. Treatment usually involves the use of antimalarial medications such as atovaquone combined with azithromycin or clindamycin combined with quinine. Prompt diagnosis and treatment are crucial to prevent complications such as respiratory failure or renal failure, especially in high-risk populations. Babesiosis is considered a tropical disease, although it is increasingly recognized in temperate regions, particularly in the northeastern and upper midwestern United States.
Detailed patient history, including travel and exposure history, laboratory results, and treatment plans.
Patients presenting with fever and hemolytic anemia after tick exposure.
Ensure accurate documentation of co-infections and laboratory findings.
Comprehensive patient history and symptom documentation, including any tick bites.
Patients with flu-like symptoms following outdoor activities in endemic areas.
Awareness of local endemic areas and potential for misdiagnosis.
Used when testing for Babesia in patients with suspected babesiosis.
Document the reason for testing and any relevant clinical findings.
Infectious disease specialists should ensure comprehensive documentation of patient history.
Common symptoms include fever, chills, sweats, headache, myalgia, and fatigue. Severe cases may lead to hemolytic anemia and complications.
